Search
Showing results for "1"
This project aims to investigate the impact of a non-severe burn injury on children's health for life.
One in three children in WA suffer iron deficiency leading to poor sleep, fussy eating, and behavioural difficulties. This project aims to develop mechanisms to prevent and treat the problems before they become clinically significant and translate findings to other communities to improve childhood wellness.
News & Events
Getting the most out of the CGM schemeIf your child/adolescent has been approved to use CGM but decides they do not want to use it, it is important to complete a NDSS change/termination form, which needs to be returned to your clinic team.
News & Events
3rd European Rett Syndrome Conference, October 17-19, Maastricht, The NetherlandsFollowing last year's World Rett Syndrome Congress held in New Orleans, the 3rd European Rett Syndrome Conference was held in the Netherlands over 3 days.
The aim of the study is the early identification of problems with the current flu vaccines, and providing parents and professionals with up to date information.
This study is aiming to investigate how sun exposure and time outside impacts the health of your child’s eye and eye growth, over a period of rapid growth in their lives.
Research
CAGE-defined promoter regions of the genes implicated in Rett SyndromeA comprehensive picture of the regulatory regions of the three genes involved in Rett Syndrome
Research
The genetic and epigenetic landscapes of the epithelium in asthmaGenetic factors in airway epithelial cells that are functionally associated with asthma pathogenesis
Research
Development of a scale to evaluate midwives' beliefs about assessing alcohol use during pregnancyPrenatal alcohol exposure is an important modifiable cause of adverse fetal outcomes during and following pregnancy.
Research
Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179OLIG2-expressing tumor stem cells have been shown to drive recurrence in Sonic Hedgehog (SHH)-subgroup medulloblastoma (MB) and patients urgently need specific therapies to target this tumor cell population.